Compare · INNV vs OPCH
INNV vs OPCH
Side-by-side comparison of InnovAge Holding Corp. (INNV) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both INNV and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.15B, about 3.2x INNV ($1.00B).
- Over the past year, INNV is up 100.4% and OPCH is down 33.6% - INNV leads by 134.0 points.
- OPCH has been more active in the news (13 items in the past 4 weeks vs 5 for INNV).
- Both have 15 recent analyst ratings on file.
- Company
- InnovAge Holding Corp.
- Option Care Health Inc.
- Price
- $7.62+3.25%
- $21.02+4.71%
- Market cap
- $1.00B
- $3.15B
- 1M return
- +0.73%
- +2.51%
- 1Y return
- +100.39%
- -33.64%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 5
- 13
- Recent ratings
- 15
- 15
InnovAge Holding Corp.
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, dental, mental health and psychiatric, meals, and activities, as well as physical, occupational, and speech therapy; transportation to the PACE center and third-party medical appointments; and care management. It serves approximately 6,600 PACE participants in the United States of America; and operates seventeen PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest INNV
- President and COO Browne Jennifer was granted 67,842 shares (SEC Form 4)
- CHIEF LEGAL OFFICER Damato Nicole covered exercise/tax liability with 23,064 shares, decreasing direct ownership by 7% to 296,743 units (SEC Form 4) to satisfy withholding obligation
- CHIEF EXECUTIVE OFFICER Blair Patrick T covered exercise/tax liability with 21,969 shares, decreasing direct ownership by 3% to 687,103 units (SEC Form 4) (for withholding tax)
- SEC Form 3 filed by new insider Browne Jennifer
- InnovAge Holding Corp. filed SEC Form 8-K: Regulation FD Disclosure
- InnovAge Holding Corp. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- InnovAge Appoints Jennifer Browne as President and Chief Operating Officer
- InnovAge Holding Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2026
- InnovAge to Announce Fiscal Third Quarter 2026 Financial Results and Host Conference Call Tuesday, May 5, 2026
Latest OPCH
- Goldman initiated coverage on Option Care Health with a new price target
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
- Director Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)
- Director Sullivan Timothy P was granted 13,833 shares, increasing direct ownership by 19% to 87,216 units (SEC Form 4)
- Director Bodem Barbara W. was granted 8,997 shares, increasing direct ownership by 74% to 21,087 units (SEC Form 4)
- Director Wright Norman L. was granted 8,997 shares, increasing direct ownership by 58% to 24,498 units (SEC Form 4)